Previous Article | Next Article 
Infection and Immunity, April 1999, p. 1640-1645, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Defensins Impair Phagocytic Killing by Neutrophils
in Biomaterial-Related Infection
S. S.
Kaplan,1,2,*
R. P.
Heine,3 and
R. L.
Simmons2
Departments of
Pathology1 and
Surgery,2 University of Pittsburgh
School of Medicine, Pittsburgh, Pennsylvania 15261, and
Department of Obstetrics, Gynecology, and Reproductive
Sciences, Magee Women's Research Institute, Pittsburgh,
Pennsylvania 152133
Received 21 September 1998/Returned for modification 2 November
1998/Accepted 5 January 1999
 |
ABSTRACT |
The implantation of foreign material carries a risk of infection
which frequently is resistant to all treatment short of removing the
implant. We have previously shown that these materials activate neutrophils by contact, leading to production of oxygen free radicals accompanied by release of granule products. Such activation
further results in depletion of local host defenses, including the
capacity of biomaterial-activated neutrophils to kill bacteria. Among
the granule products released from neutrophils are small cationic antibacterial peptides (human neutrophil peptides [HNP]) known as
defensins. Here we tested the hypothesis that defensins, released from activated neutrophils onto the surface of biomaterials, might play
a role in the deactivation of subsequent neutrophil
populations. Incubation of neutrophils with purified HNP resulted in a
dose-related impairment of stimulus-induced oxygen radical
production and of phagocytic killing. Furthermore, fresh neutrophils
added to biomaterial-associated neutrophils exhibited impaired
phagocytic killing. This impairment could be abrogated by antibody to
HNP but not by an irrelevant antibody. Taken together, these
observations support the idea that neutrophils activated at a material
surface can create, by means of HNP release, an environment hostile to
their microbicidal function and that of their infiltrating brethren.
 |
INTRODUCTION |
Implantable biomaterials, virtually
indispensable in medical practice (16, 22, 29) and with an
excellent overall success rate, have continued to be infection prone,
with enormous social and economic consequences (13, 14, 23, 25,
26, 40, 66, 76). These infections tend to be persistent and
refractory to antibiotics and often require removal of the implant to
clear the infection (14, 22, 40). In this sense, they
resemble abscesses, which require surgical drainage in order to be eradicated.
The pathogenic mechanisms of this refractoriness to treatment, however,
have remained obscure. Contributory factors include bacterial virulence
properties, such as slime production (4, 10, 23, 31, 56,
60), as well as properties of specific biomaterials which
increase microbial adherence or alter inflammatory changes (1, 2,
7, 9, 12, 23, 24, 27, 30, 51, 53, 58, 70, 71, 77, 78) and
impaired phagocytic host defenses even in the absence of microbial
colonization (34-36, 57, 59, 64, 78, 79).
Neutrophils rapidly become associated with any implanted biomaterial in
vivo and, under conditions permissive of normal function, should be
capable of phagocytic host defense. Previous work by others
(2, 15, 21, 27, 30, 39, 41, 52, 53, 57-59, 64, 77-79)
and in our laboratory (34-36), however, has shown that
biomaterial-associated neutrophils become prematurely
activated by contact with the materials themselves and shortly
thereafter lose the capacity to become activated in response to normal
subsequent stimuli. More importantly, these biomaterial-associated
neutrophils appear to actually induce a dysfunctional impaired
activation of incoming fresh neutrophils (36, 78, 79).
Normally, neutrophils effect phagocytic host defense by ingesting and
killing invading microorganisms (3, 54, 69). The killing of
microbes occurs as a consequence of reactive oxygen intermediates (ROI)
formed during the process of phagocytosis together with bioactive
constituents from granules which discharge into the phagocyte vacuole
(5, 62, 63, 72, 73). These constituents include
myeloperoxidase, which, when combined with H2O2 and chloride, produces hypochlorous acid
within the phagocytic vacuole, as well as small highly cationic
peptides (human neutrophil peptides [HNP]), also known as
defensins. The defensins HNP1, -2, and -3 comprise 5% of a
neutrophil's total protein (19, 44, 46). HNP contain 29 to
35 amino acid residues, and because of their charge and their tendency
to form multimeric subunits, they insinuate themselves into
microbial cell membranes (gram-positive and gram-negative bacteria,
fungi, and viruses) (11, 45, 47, 61), produce
voltage-sensitive channels, and thereby permeabilize the membrane
(33). HNP also are known to damage eukaryotic cells, such as tumor cells (48, 65) and human neutrophils
(75), and in a cell-free system they have been shown to
inhibit NADPH oxidase (67). This cytotoxicity depends
in part on the lipid composition of the target cell membrane
(28) and requires metabolic activity in the target cells
(49). In addition, hydrogen peroxide acts
synergistically with HNP to induce cytotoxicity (50).
Along with permeabilization, DNA strand breaks in some target cells have been reported (20, 49), and while the mechanism has not been determined, a direct interaction between defensin and DNA is suspected.
Because HNP may be toxic to polymorphonuclear leukocytes (PMN)
(67, 75), and because material-activated neutrophils could be expected to release HNP from their granules (5, 62, 63, 72,
73), we proposed that the dysregulated functioning of incoming
fresh neutrophils (36) might be induced by these
released HNP. To further explore this idea in the context of
biomaterial-induced changes, the effect of purified HNP on
phagocytic killing by neutrophils was evaluated and demonstrated a
dose-related cytotoxicity of HNP1 and HNP2 ameliorated by antibody
to HNP. These data support the idea that released HNP contribute to an
environment hostile to host defense at the biomaterial surface.
 |
MATERIALS AND METHODS |
Cells and reagents.
Blood was obtained from healthy human
donors. Neutrophils were isolated by density gradient centrifugation
according to the method of Boyum (6), as previously
described (37, 43), and suspended in modified Krebs Ringer
phosphate buffer, pH 7.4 (16 mM Na2HPO4, 123 mM
NaCl, 0.5 mM CaCl2, 0.5 mM MgSO4, 5 mM KCl, and
4.4 mM glucose) (KRPG) (35). In some studies, the KRPG included 10% autologous plasma. Each neutrophil donor provided cells
for a single day's experiments. Cell numbers were determined with
Coulter (Hialeah, Fla.) electronic instruments, and the cells were
suspended at a concentration of 2 × 106/ml. The
preparations were evaluated with DiffQuick-stained cytospin preparations and were uniformly >95% neutrophils. Viability was determined by trypan blue dye exclusion and was uniformly >95%. Stock
solutions of formyl methionyl leucyl phenylalanine (fMLP), phorbol
myristate acetate (PMA), and opsonized zymosan (OZ) were prepared as
previously described (34). Purified human neutrophil defensins HNP1 and HNP2 were obtained from Sigma Chemical Co., St.
Louis, Mo., and stored at
20°C until needed. At that time, the HNP were suspended in phosphate-buffered saline (PBS) at a concentration of 25 µg/ml and were diluted in PBS so that the PMN
were incubated with 10 to 35 µg of HNP/ml. Monoclonal antibody to HNP
(D1-1 immunoglobulin G1, a neutralizing antibody) was a generous gift
of T. Ganz, University of California
Los Angeles School of
Medicine, Los Angeles. The stock solution of 10,000 µg/ml (10 mg/ml)
was diluted in PBS to the desired concentration just before use.
Antibody to VCAM-1 (an irrelevant immunoglobulin G1 control antibody)
was a generous gift from T. Carlos, University of Pittsburgh. It was in
a stock solution of 3,600 µg/ml (3.6 mg/ml) and was appropriately
diluted in PBS just before use. Unless specified, all other materials
were reagent grade and were obtained from Sigma Chemical Co.
Superoxide release.
Human neutrophils (106) were
preincubated with purified human neutrophil defensins and then were
placed into triplicate wells of 24-well plates in KRPG. Cytochrome
c was added with and without fMLP, PMA, OZ, or
Staphylococcus aureus, and the plates were incubated at
37°C for 30 min. Superoxide dismutase was present in a fourth well.
The superoxide dismutase-inhibitable cytochrome c
reduction was determined after 30 min, at which time the plates
were placed in melting ice and centrifuged and the supernatants were
transferred to 96-well plates. The data are expressed as nanomoles of
O2
/106 cells.
Microbe killing.
The effects of biomaterial association, of
antibody to HNP, and of HNP1 and HNP2 on microbe killing were
determined by clonal-culture techniques as previously described,
using S. aureus D2C as the target organism
(38).
The effect of HNP1 and HNP2 on the ability of PMN to kill staphylococci
was determined by preincubating PMN in KRPG (106/ml) in 12- by 75-mm test tubes with various concentrations of HNP1 and HNP2 at
37°C for 1 h. The 1-h incubation was based on published
data demonstrating that toxicity for mammalian eukaryotic cells
requires 1 h for completion and irreversibility (44,
49). The PMN were then centrifuged, washed once with KRPG, and
resuspended in KRPG plus 10% plasma; 5 × 105 cells
were put in 25-ml Erlenmeyer flasks and placed in a rotary shaking
water bath. After 10 min, an inoculum of S. aureus was added (Staphylococcus/neutrophil ratio, 10:1). The samples
were swirled to mix them, and a 10-µl sample was removed immediately after the addition of bacteria (the time zero sample). Samples (10 µl) were removed at 2 and 24 h, and the numbers of viable staphylococci were determined.
The effect of biomaterial-associated PMN on the microbicidal activity
of a fresh inoculation of PMN was determined by first
incubating the
PMN in KRPG in 24-well culture dishes for 1 h at
37°C and then
adding a similar number of PMN and continuing the
incubation for 1 h more. The PMN were removed from the wells after
the addition of EDTA
to reverse the adhesion phenomenon and then
centrifuged and washed
prior to being resuspended in KRPG and
placed in the wells of a clean
24-well culture dish. For control
conditions, PMN were stored at 37°C
for 1 h in a test tube and
then added to complete buffer
containing 10% plasma.
S. aureus was added 10 min
later, and bacterial colony counts were made
at the time of
S. aureus addition as well as after 2 and 24
h.
To determine if incubating PMN with antibody to HNP (D1-1) resulted in
improved staphylocidal activity of fresh PMN added
to
biomaterial-associated PMN, various concentrations of the antibody
to
HNP (2 to 200 µg/ml) or to VCAM at 200 µg/ml were placed in
the
wells of 24-well plates just prior to the addition of the
initial
inoculum of PMN. The PMN were in contact with the wells,
with and
without the presence of antibody, for 1 h at 37°C. In
some
experiments, 50 and 80% plasma were added instead of antibody.
A
second inoculation of PMN was added, as described above, and
incubation
continued for 1 h more at 37°C. These PMN, washed and
resuspended in KRPG with 10% plasma, were transferred to a fresh
well;
staphylococci were then added, and incubation continued
for 24 h
as described
above.
Defensin assay.
The amount of available defensins in PMN
before and after exposure to polystyrene was determined by Panyutich's
method. Briefly, this is a "sandwich-type" enzyme immunoassay with
a monoclonal antibody for capture and a biotinylated monoclonal
antibody for detection. Cetyltrimethyl ammonium bromide was used to
counteract nonspecific binding of HNP to surfaces. The assay detects
HNP with a range of 0.5 to 16 ng/ml.
Statistical evaluation.
Calculations of statistical
significance were done with Student's t test or the paired
t test. Significance was defined as a P value of
0.05.
 |
RESULTS |
Figure 1 illustrates the effect on
bacterial viability of adding a secondary inoculum of fresh neutrophils
to polystyrene wells containing the primary inoculum of
neutrophils which had been on the polystyrene surface for 1 h.
These neutrophils killed 38% ± 4% of the S. aureus organisms in 2 h and killed 41% ± 8% of the
organisms by 24 h. In contrast, when the S. aureus
organisms were added within 10 min of the primary inoculation of PMN
onto the polystyrene, 65% ± 3% of the S. aureus
organisms were killed in 2 h and 88% ± 2% were killed by
24 h (P
0.001). These data indicate that the
association of the first inoculum with polystyrene for 1 h
down-regulated microbe killing by the secondary inoculum.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of polystyrene preincubation on staphylocidal
activity. The percent viable staphylococci during 24 h of
incubation with neutrophils is shown. Control neutrophils were
inoculated with S. aureus at the same time the cells
were placed in the polystyrene wells ( ). The decrease in the number
of viable staphylococci occurred rapidly during the first 2 h of
incubation and more slowly after that. These cells killed 65% ± 3%
of the inoculum after 2 h and 88% ± 2% of the inoculum after
24 h. The figure also shows the effect on the staphylocidal
behavior of fresh neutrophils added to neutrophils that had been
preincubated for 1 h in polystyrene wells ( ). These cells
killed only 38% ± 4% of the inoculum at 2 h and 41% ± 8% of the inoculum at 24 h (P 0.001 compared
to the control at both of these times). The error bars indicate
standard errors.
|
|
One likely cause for this effect was the release of granule products,
such as HNP, with documented (11, 19, 20, 44-50, 61, 65)
toxicity against both eukaryotic and prokaryotic cells. We therefore
examined the supernatants of polystyrene-associated PMN (after 1 h
of association) for the presence of HNP. Less than 1,000 ng was
detected, too low a concentration to explain our results based on
published data. However, since strongly cationic HNP readily adhere to
negatively charged surfaces such as plastic (55)
and to cells (17), the poor recoverability of the HNP may have represented an artifact. Residual intracellular HNP from control PMN and from PMN after polystyrene association was then measured and is shown in Fig. 2. In this
study, a marked reduction in the detectable HNP content of
biomaterial-associated cells was seen, from 3,616 ± 1,098 ng/ml/106 PMN extractable in control cells to 1,313 ± 183 ng/ml extractable 30 min after polystyrene exposure and 886 ± 277 ng/ml extractable at 2 h. We also evaluated defensin content
in cells exposed to woven Dacron and Silastic, finding 453 ± 230 and 1,275 ± 215 ng/ml, respectively. These results are consistent
with the idea that PMN associated with biomaterials discharge their
granular HNP and that the released HNP become associated with or
inactivated by the polystyrene. To test this hypothesis, we added
purified HNP1 and HNP2 to polystyrene plates in the absence of
cells. The supernatants were analyzed for residual HNP. Detectable
HNP disappeared within 15 min, with only 2% remaining in the
supernatant. These results are consistent with those of others
(55), showing rapid association of HNP with plastic.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 2.
Extractable defensin of control neutrophils (A), cells
which had been incubated on polystyrene for 30 min (B) and for 2 h
(C), and neutrophils incubated for 2 h on woven Dacron (D) or
silastic (E). Exposure to all three materials was associated with
significantly reduced defensin content (P 0.01 under
all conditions). The error bars indicate standard errors.
|
|
To determine whether HNP might impair PMN staphylocidal activity,
commercially available purified HNP were incubated with PMN for 1 h at 37°C. The ability of these incubated and washed PMN to kill
S. aureus is shown in Fig. 3. Figure
3A shows that HNP1, at a concentration of
35 µg/ml, impaired the staphylocidal activity of PMN such that only
31% ± 13% and 37% ± 11% of the inoculum was killed after 2 and
24 h of incubation, respectively (P
0.01
compared with the control or with HNP1 at 10 µg/ml and P
0.03 compared with HNP1 at 25 µg/ml). Incubation of PMN with HNP1 at 25 µg/ml also compromised staphylocidal activity, but the
inhibition was more variable. Figure 3B shows that HNP2 is a more
potent inhibitor of PMN staphylocidal activity. The use of 25 µg/ml
almost completely abrogated staphylocidal activity after 2 and 24 h of incubation (P
0.01 compared to the control and
to HNP2 at 10 µg/ml). As little as 15 µg of HNP2/ml also
significantly impaired staphylocidal activity (P
0.01 at 2 and 24 h compared to the control and P
0.05 at 2 and 24 h compared to HNP2 at 10 µg/ml). HNP2,
therefore, was far more toxic to PMN than HNP1 was. In addition, Fig.
4 shows that HNP1, at 35 µg/ml,
significantly impaired the ability of neutrophils to produce superoxide
following stimulation with any of the inducing agents. Parallel
experiments were performed with HNP2, which demonstrated complete
abrogation of superoxide release at 20 µg/ml (data not shown). These
cytotoxic correlations of HNP and the incubation conditions are
consistent with the known conditions for cytotoxicity of HNP for
eukaryotic cells (18, 32). Despite these inhibitory effects
of HNP on microbe killing and O2
release, HNP
had no effect on PMN viability as determined by trypan blue dye
exclusion during the first 5 h following PMN incubation with 35 µg of HNP1/ml, and viability was 73% after 24 h.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Effect of HNP1 on staphylocidal activity. The effect
of preincubating neutrophils for 1 h with several concentrations
of HNP1 (or buffer control) is shown. The cells were washed and
resuspended in KRPG with 10% plasma and then inoculated with
staphylococci. The control cells ( ) killed 91% ± 1% of the
inoculum after 2 h and 88% ± 2% of the inoculum after 24 h. HNP1 at 10 µg/ml ( ) did not affect staphylocidal
activity. HNP1 at 25 µg/ml ( ) reduced staphylocidal activity to
75% ± 7% killed at 24 h (P 0.03 compared to
the control or HNP1 at 10 µg/ml). HNP1 at 35 µg/ml ( ) reduced
staphylocidal activity to 31% ± 13% killed at 2 h and 37% ± 13% killed at 24 h (P 0.01 compared to the
control). (B) Effect of HNP2 on staphylocidal activity. The effect of
HNP2 on the staphylocidal activity of human PMN is more potent than the
effect of HNP1 shown in panel A. Although HNP2 at 10 µg/ml ( ) did
not significantly affect killing, HNP2 at 15 µg/ml ( )
partially inhibited staphylocidal activity: 41% ± 20% of the
inoculum was killed at 2 h, and 40% ± 8% was killed at 24 h compared to 89% ± 5% and 85% ± 2% killed at 2 and 24 h by
control cells ( ) (P 0.01 at 2 and 24 h).
HNP2 at 25 µg/ml ( ) almost completely abrogated staphylocidal
activity: 5% ± 15% killed at 2 h and 8% ± 20% killed at
24 h (P 0.01 at 2 and 24 h compared to the
control; P 0.05 at 2 and 24 h compared to HNP2
at 10 µg/ml).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of HNP1 on superoxide release. Incubation of
neutrophils with 35 µg of HNP1/ml ( ) significantly reduced the
superoxide release of unstimulated (unstim) cells and of cells
stimulated with PMA, fMLP, and OZ (P 0.01) compared
to unexposed (control) cells ( ). Incubation with 17.5 ( ) and 25 ( ) µg of HNP1/ml had little effect (mean of two experiments).
|
|
To further evaluate the likelihood that HNP released from
polystyrene-associated PMN can act to disable PMN (Fig. 1),
antibody to HNP was added to the first inoculum of PMN
placed in the polystyrene wells. Figure 5
shows that this antibody reversed the cytotoxic effect at both time
points (P
0.05 at 2 h; P = 0.0001 at 24 h) when killing in the presence and absence of
200 µg of specific anti-HNP antibody/ml were compared. Lower
concentrations of antibody (2 to 50 µg/ml) were without effect (data
not shown), as was the use of 200 µg of an irrelevant antibody
(antibody to VCAM)/ml at 2 and 24 h.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of antibody to HNP on polystyrene-associated
inhibition of staphylocidal activity. Compared to control cells, in
which staphylococci were added without a prior 1-h incubation of PMN on
polystyrene ( ), staphylocidal activity was impaired when fresh
neutrophils were added to the polystyrene-exposed neutrophils ( ),
but this is overcome by addition of monoclonal antibody specific for
HNP ( ) but not by irrelevant antibody to VCAM ( ) prior to the
addition of fresh neutrophils. This effect was highly significant at
both 2 and 24 h after the inoculation of neutrophils with
staphylococci (P = 0.00008).
|
|
 |
DISCUSSION |
An implanted biomaterial foreign body has paradoxical effects; it
induces the accumulation of phagocytes and at the same time can become
the nidus of intractable bacterial infection. In fact, the greater the
ability of a foreign body to induce a neutrophilic infiltrate, the
greater its susceptibility to infection (12, 13, 30). Our
previous work has indicated that PMN often become activated at
the surfaces of biomaterials (34). The PMN can release
chemoattractant substances, which would serve to attract fresh
PMN to the surface (36). Such an event would be expected to
potentiate host defenses but seems to have the opposite effect. We
found that PMN, once in contact with biomaterials, rapidly lose their
capacity to generate superoxide and are relatively impotent in
their microbicidal activity (36). We subsequently showed
that when fresh PMN were added to a surface upon which there
had been a prior inoculum of PMN, the fresh PMN became inactive (36). These data, therefore, are consistent with the
idea that the infectivity at biomaterial surfaces may be due at least
in part to releasant-mediated autacoid and paracoid damage of the PMN themselves, rendering such wounds susceptible to even small inocula. Our present data support and extend our previous
observation that fresh PMN, added to polystyrene-associated PMN
and then removed and washed free of mediators, acquire a
profoundly compromised staphylocidal activity. The data strongly
suggest that a cytotoxic agent(s) is released when PMN contact
polystyrene. These cytotoxic agents can further compromise the
functioning of bystander PMN.
Neutrophils have considerable cytotoxic potential and play a role in
many kinds of inflammatory reactions, ranging from autoimmune processes
to reperfusion injury. This cytotoxic potential includes the
metabolic products derived from the production of oxidative free
radicals and the cytoactive granule constituents. The small cationic HNP, the defensins, comprise a potential subset of
cytotoxic elements with well-established toxicity against prokaryotic
and eukaryotic cells. The toxicity of HNP for bacteria is based on the
ability of HNP to permeabilize the outer and inner membranes of
susceptible bacteria (44) by the formation of ion channels (33) and by antagonizing intracellular signaling mediated by protein kinase C (8). These actions, however, are not
limited to HNP, since Yeaman et al. demonstrated a similar, although
not identical, antibacterial action of peptides from platelets
(74). While several groups demonstrated that HNP were toxic
to eukaryotic as well as to prokaryotic cells, the mechanism of injury
to mammalian target cells is less well established. These actions have
been reviewed by Kagan et al. (32), who indicated that there
are three interdependent actions, including (i) membrane binding due to
electrostatic forces, followed by (ii) insertion into the membrane or
internalization of the HNP (49). The third step (iii)
includes DNA injury (20, 47), inhibition of NADPH oxidase
(67, 68), and inhibition of protein kinase C (8).
The initial binding becomes irreversible within 1 h of
association, and although permeability to trypan blue dye was not
observed in our study, the concentration of HNP may not have been high
enough, since Lehrer indicated that HNP1 at 50 µg/ml was needed to
see this in PMN (personal communication). Mammalian cells have also
been shown to require an energized target cell membrane, since
metabolic inhibitors which do not effect initial binding do inhibit
defensin-induced permeabilization. Yomogida et al. (75)
specifically documented some of the results of HNP-induced cytotoxicity
in PMN. These included diminished ROI formation, impaired phagocytosis
(not due to impaired particle attachment), and increased adherence. Our
work supports these findings and also demonstrates that the ability of
PMN to kill bacteria is severely compromised.
Wright and Gallin (73) showed that PMN degranulate upon
association with artificial materials in vitro. Klock and Bainton demonstrated that PMN associated with nylon wool initially degranulate but subsequently exhibit abnormal bactericidal activity
(42). Our finding that PMN in polystyrene wells for 1 h
lose intracellular defensin content and concurrently impair the
function of subsequently added neutrophils strongly implicates
the granular defensins in PMN dysfunction. We
demonstrate in this paper that in the presence of antibody to
HNP, but not of isotype-identical irrelevant antibody, the
PMN placed in the polystyrene wells did not exert a cytotoxic effect on a fresh inoculum of PMN. The staphylococci added with these PMN were killed normally. These data support our hypothesis that HNP (among other possible releasants) from
material-associated neutrophils play a significant role in the
impairment of cell function at the material surface. Whether or not the
defensins, which are apparently readily adsorbed onto polystyrene,
exert their anti-PMN function after adsorption is an important question that will require further study.
This work has not addressed the particular mechanisms by which HNP
damage PMN in our system. We do not assert that defensin-mediated damage is the only route to neutrophil impairment on biomaterial surfaces, and Tal et al. (68) demonstrated that cationic
proteins other than HNP may damage PMN oxidative activity. However,
neutrophils also release proinflammatory mediators, such as
oxidative free radicals, interleukin-8, and metabolites of arachidonic
acid, including leukotrienes and prostaglandins, all of which could serve transiently to augment and potentially harm cell function. Our
studies, however, clearly demonstrate that purified HNP incubated with
PMN severely compromised phagocytic killing of staphylococci when used
at a concentration of 25 µg/ml for HNP2, a concentration determined
by others to be toxic to eukaryotic cells, and at a concentration of 35 µg/ml for HNP1. While most of our studies were performed after a 1-h
incubation with HNP to ensure that the interaction of HNP with the cell
membrane was irreversible, several studies also were performed after a
much shorter (15-min) incubation. These studies also demonstrated
profound inhibition of the PMN's killing of staphylococci (data not
shown). These concentrations are much lower than HNP concentrations
found in phagocytic vacuoles, so they could conceivably be achieved in the microenvironment of the degranulating cell. At lower concentrations which did not diminish phagocytic killing of staphylococci, superoxide production in response to a peptide stimulus (but not to a phagocytic stimulus) appeared to be very slightly greater than it was in the
absence of HNP. At higher concentrations (sufficient to impair phagocytic killing), superoxide production was almost totally inhibited. These data are consistent with earlier studies in the 24-well culture plate model system, which demonstrated that the ROI
production of secondary-inoculum PMN was diminished (36). The data are consistent with the finding that this
biomaterial-associated impairment of ROI production could also be
defensin related. It is even conceivable that defensins with intense
cationic charge actually scavenge O2
and
other antimicrobial radicals, such as ·NO. While events on one
material should not be extrapolated to occurrences on other materials,
preliminary studies have suggested that neutrophils placed on materials
commonly used in medical practice, such as woven Dacron (a highly
activating material) or Silastic (a less activating material but
nevertheless associated with increased infectivity in vivo) also become
depleted of defensins, with depletion on woven Dacron much greater than
that on Silastic.
Taken together, these studies support our observations that neutrophil
dysregulation at a material surface can contribute to microbial
survival. It seems clear that released neutrophil products play some
role in this dysregulation. These studies further show that one of
these products is the granule constituent HNP, which not only plays an
important role in host defense against microbial infection but can,
under appropriate conditions, create an environment hostile to host
defense processes.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge helpful discussions with Robert
E. Lehrer, who helped to point us in the right direction.
Expert technical assistance was provided by Amy Sartori and Leo
Mortimer, and expert secretarial assistance was provided by Tracy
Garchak and Rebecca Pfeifer.
This work was supported by National Institute of Health grant
R01-GM-41734.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Pittsburgh Medical Center, Room 5930 MT CHP, 200 Lothrop St.,
Pittsburgh, PA 15213. Phone: (412) 647-3772. Fax: (412) 647-8567. E-mail: kaplanss{at}msx.upmc.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Absolom, D. R.,
F. F. Lamberti,
Z. Policova,
W. Zingg,
C. J. van Oss, and A. W. Neumann.
1983.
Surface thermodynamics of bacterial adhesion.
Appl. Environ. Microbiol.
46:90-97[Abstract/Free Full Text].
|
| 2.
|
Arizono, T.,
M. Oga, and Y. Sugioka.
1992.
Increased resistance of bacteria after adherence to polymethyl methacrylate.
Acta Orthop. Scand.
63:661-664[Medline].
|
| 3.
|
Babior, B. M.
1984.
Oxidants from phagocytes: agents of defense and destruction.
Blood
64:959-966[Free Full Text].
|
| 4.
|
Baddour, L. M.,
G. D. Christensen,
M. G. Hester, and A. L. Bisno.
1984.
Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence.
J. Infect. Dis.
150:721-727[Medline].
|
| 5.
|
Borregaard, N.,
K. Lollike,
L. Kyeldsen,
H. Sengelov,
L. Bastholm,
M. H. Nielsen, and D. F. Bainton.
1993.
Human neutrophil granules and secretory vesicles.
Eur. J. Haematol.
51:187-198[Medline].
|
| 6.
|
Boyum, A.
1968.
Isolation of mononuclear cells and granulocytes from human blood.
Scand. J. Clin. Lab. Investig.
21:77-89[Medline].
|
| 7.
|
Brunstedt, M. R.,
S. Sapatnekar,
K. R. Rubin,
K. M. Kieswetter,
N. P. Ziats,
K. Merritt, and J. M. Anderson.
1995.
Bacteria/blood/material interactions. I. Injected and preseeded slime-forming Staphylococcus epidermidis in flowing blood with biomaterials.
J. Biomed. Mater. Res.
29:455-466[Medline].
|
| 8.
|
Charp, P. A.,
W. G. Rice,
R. L. Raynor,
E. Reimund,
J. M. Kinkade,
T. Ganz,
M. E. Selsted,
R. I. Lehrer, and J. F. Kuo.
1988.
Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils.
Biochem. Pharmacol.
37:951-956[Medline].
|
| 9.
|
Christensen, G. D.,
W. A. Simpson,
A. L. Bisno, and E. H. Beachey.
1982.
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.
Infect. Immun.
37:318-326[Abstract/Free Full Text].
|
| 10.
|
Christensen, G. D.,
W. A. Simpson,
A. L. Bisno, and E. H. Beachey.
1983.
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis.
Infect. Immun.
40:407-410[Abstract/Free Full Text].
|
| 11.
|
Daher, K. A.,
M. E. Selsted, and R. I. Lehrer.
1986.
Direct inactivation of viruses by human granulocyte defensins.
J. Virol.
60:1068-1074[Abstract/Free Full Text].
|
| 12.
|
Dougherty, S. H.
1988.
Pathobiology of infection in prosthetic devices.
Rev. Infect. Dis.
10:1102-1117[Medline].
|
| 13.
|
Dougherty, S. H., and R. L. Simmons.
1982.
Infections in bionic man: the pathobiology of infections in prosthetic devices part I.
Curr. Probl. Surg.
19:221-264.
|
| 14.
|
Dougherty, S. H., and R. L. Simmons.
1989.
Endogenous factors contributing to prosthetic device infections.
Infect. Dis. Clin. N. Am.
3:199-209[Medline].
|
| 15.
|
Falck, P.
1995.
Characterization of human neutrophils adherent to organic polymers.
Biomaterials
16:61-66[Medline].
|
| 16.
|
Friedman, D. W.,
P. J. Orland, and R. S. Greco.
1994.
Biomaterials: an historical perspective, p. 1-12.
In
R. S. Greco (ed.), Implantation biology: the host response and biomedical devices. CRC Press, Boca Raton, Fla.
|
| 17.
|
Ganz, T.
1987.
Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes.
Infect. Immun.
55:568-571[Abstract/Free Full Text].
|
| 18.
|
Ganz, T., and R. I. Lehrer.
1995.
Defensins.
Pharmacol. Ther.
66:191-205[Medline].
|
| 19.
|
Ganz, T.,
M. E. Selsted,
D. Szklarek,
S. S. Harwig,
K. Daher,
D. F. Bainton, and R. I. Lehrer.
1985.
Defensins: natural peptide antibiotics of human neutrophils.
J. Clin. Investig.
76:1427-1435.
|
| 20.
|
Gera, J. R., and A. Lichtenstein.
1991.
Human neutrophil peptide defensins induce single strand DNA breaks in target cells.
Cell. Immunol.
138:108-120[Medline].
|
| 21.
|
Gormley, I. P.,
M. J. Kowolik, and R. T. Cullen.
1985.
The chemiluminescent response of human phagocytic cells to mineral ducts.
Br. J. Exp. Pathol.
66:409-416[Medline].
|
| 22.
|
Greco, R. S.
1997.
Body parts: in vivo veritas.
J. Biomed. Mater. Res.
34:409-410[Medline].
|
| 23.
|
Gristina, A. G.
1987.
Biomaterial centered infection: microbial adhesion versus tissue integration.
Science
237:1588-1595[Abstract/Free Full Text].
|
| 24.
|
Gristina, A. G., and J. W. Costerton.
1985.
Bacterial adherence to biomaterials and tissue.
J. Bone Joint Surg.
67:264-273[Abstract/Free Full Text].
|
| 25.
|
Gristina, A. G.,
J. J. Dobbins,
B. Giammara,
J. C. Lewis, and W. C. DeVries.
1988.
Biomaterial-centered sepsis and the total artificial heart microbial adhesion versus tissue integration.
J. Am. Med. Assoc.
259:870-874[Abstract/Free Full Text].
|
| 26.
|
Guo, W.
1993.
Infections associated with intraperitoneal biomaterials. Bulletin no. 92 of the Department of Surgery, Lund University, p. 9-12.
Lund University, Lund, Sweden.
|
| 27.
|
Hogt, A. H.,
J. Dankert, and J. Feijen.
1985.
Adhesion of Staphylococcus epidermidis and Staphylococcus saprophyticus to a hydrophobic biomaterial.
J. Gen. Microbiol.
131:2485-2491[Abstract/Free Full Text].
|
| 28.
|
Hristova, K.,
M. E. Selsted, and S. H. White.
1997.
Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins.
J. Biol. Chem.
272:24224-24333[Abstract/Free Full Text].
|
| 29.
|
Hubbell, J. A.
1995.
Biomaterials in tissue engineering.
Bio/Technology
13:565-576[Medline].
|
| 30.
|
Hunt, J. A.,
B. F. Flanagan,
P. J. McLaughlin,
I. Strickland, and D. F. Williams.
1996.
Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNF production.
J. Biomed. Mater. Res.
31:139-144[Medline].
|
| 31.
|
Johnson, G. M.,
D. A. Lee,
W. E. Regelmann,
E. D. Gray,
G. Peters, and P. G. Quie.
1986.
Interference with granulocyte function by Staphylococcus epidermidis slime.
Infect. Immun.
54:13-20[Abstract/Free Full Text].
|
| 32.
|
Kagan, B. L.,
T. Ganz, and R. I. Lehrer.
1994.
Defensins: a family of antimicrobial and cytotoxic peptides.
Toxicology
87:131-149[Medline].
|
| 33.
|
Kagan, B. L.,
M. E. Selsted,
T. Ganz, and R. I. Lehrer.
1990.
Neutrophil antimicrobial peptides (defensins) form voltage-dependent ionic channels in planar lipid bilayer membranes.
Proc. Natl. Acad. Sci. USA
87:210-214[Abstract/Free Full Text].
|
| 34.
|
Kaplan, S. S.,
R. E. Basford,
M. H. Jeong, and R. L. Simmons.
1992.
Biomaterial-induced alterations of neutrophil superoxide production.
J. Biomed. Mater. Res.
26:1039-1051[Medline].
|
| 35.
|
Kaplan, S. S.,
R. E. Basford,
M. H. Jeong, and R. L. Simmons.
1994.
Mechanisms of biomaterial-induced superoxide release by neutrophils.
J. Biomed. Mater. Res.
28:377-386[Medline].
|
| 36.
|
Kaplan, S. S.,
R. E. Basford,
M. H. Jeong, and R. L. Simmons.
1996.
Biomaterial-neutrophil interactions: dysregulation of oxidative functions of fresh neutrophils induced by prior neutrophil-biomaterial interaction.
J. Biomed. Mater. Res.
30:67-75[Medline].
|
| 37.
|
Kaplan, S. S.,
L. A. Caliguiri,
R. E. Basford, and U. E. Zdziarski.
1987.
Transient chemotactic defect in a child with elevated IgE.
Ann. Allergy
59:213-217[Medline].
|
| 38.
|
Kaplan, S. S., and M. A. Nardi.
1977.
Impairment of leukocyte function during sickle cell crisis.
J. Reticuloendothel. Soc.
22:499-506[Medline].
|
| 39.
|
Karlsson, C.,
H. Nygren, and M. Braide.
1996.
Exposure of blood to biomaterial surfaces liberates substances that activate polymorphonuclear granulocytes.
J. Lab. Clin. Med.
128:496-505[Medline].
|
| 40.
|
Katz, D. A., and R. S. Greco.
1994.
The pathobiology of infections associated with biomaterials.
Probl. Gen. Surg.
1994(2):209-226.
|
| 41.
|
Katz, D. A.,
B. Haimovich, and R. S. Greco.
1994.
Neutrophil activation by expanded polytetrafluoroethylene is dependent on the induction of protein phosphorylation.
Surgery
116:446-455[Medline].
|
| 42.
|
Klock, J. C., and D. F. Bainton.
1976.
Degranulation and abnormal bactericidal function of granulocytes procured by reversible adhesion to nylon wool.
Blood
48:149-161[Abstract/Free Full Text].
|
| 43.
|
Kuhns, D. B.,
S. S. Kaplan, and R. E. Basford.
1986.
Hexachlorocyclohexanes, potent stimuli of O2 production and calcium release in human polymorphonuclear leukocytes.
Blood
68:535-540[Abstract/Free Full Text].
|
| 44.
|
Lehrer, R. I.,
A. Barton,
K. A. Dahrer,
S. S. L. Harwig,
T. Ganz, and M. E. Selsted.
1989.
Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity.
J. Clin. Investig.
84:553-561.
|
| 45.
|
Lehrer, R. I.,
K. Daher,
T. Ganz, and M. E. Selsted.
1985.
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.
J. Virol.
54:467-472[Abstract/Free Full Text].
|
| 46.
|
Lehrer, R. I., and T. Ganz.
1990.
Antimicrobial polypeptides of human neutrophils.
Blood
76:2169-2181[Free Full Text].
|
| 47.
|
Lichtenstein, A.
1991.
Mechanism of mammalian cell lysis mediated by peptide defensins.
J. Clin. Investig.
88:93-100.
|
| 48.
|
Lichtenstein, A.,
T. Ganz,
M. E. Selsted, and R. I. Lehrer.
1986.
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes.
Blood
68:1407-1410[Abstract/Free Full Text].
|
| 49.
|
Lichtenstein, A. K.,
T. Ganz,
T. M. Nguyen,
M. E. Selsted, and R. I. Lehrer.
1988.
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity.
J. Immunol.
140:2686-2694[Abstract].
|
| 50.
|
Lichtenstein, A. K.,
T. Ganz,
M. E. Selsted, and R. I. Lehrer.
1988.
Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins.
Cell. Immunol.
114:104-116[Medline].
|
| 51.
|
Malangoni, M. A.,
D. H. Livingston, and J. D. Peyton.
1993.
The effect of protein binding on the adherence of staphylococci to prosthetic vascular grafts.
J. Surg. Res.
54:168-172[Medline].
|
| 52.
|
Marchant, R.,
A. Hiltner,
C. Hamlin,
A. Rabinovitch, and J. M. Anderson.
1983.
In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel.
J. Biomed. Mater. Res.
2:283-318.
|
| 53.
|
Marchant, R.,
K. Miller, and J. M. Anderson.
1984.
In vivo biocompatibility studies. V. In vivo leukocyte interactions with biomer.
J. Biomed. Mater. Res.
18:1169-1190[Medline].
|
| 54.
|
Miller, R. A., and B. E. Britigan.
1995.
The formation and biologic significance of phagocyte-derived oxidants.
J. Investig. Med.
43:39-49[Medline].
|
| 55.
|
Panyutich, A. V.,
N. N. Voitenok,
R. I. Lehrer, and T. Ganz.
1991.
An enzyme immunoassay for human defensins.
J. Immunol. Methods
141:149-155[Medline].
|
| 56.
|
Peters, G.,
R. Locci, and G. Pulverer.
1982.
Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters.
J. Infect. Dis.
146:479-482[Medline].
|
| 57.
|
Petty, W.
1978.
The effect of methylmethacrylate on bacterial phagocytosis and killing by human polymorphonuclear leukocytes.
J. Bone Joint Surg.
60A:752-757[Abstract/Free Full Text].
|
| 58.
|
Ratner, B. D.,
A. B. Johnston, and T. J. Lenk.
1987.
Biomaterial surface.
J. Biomed. Mater. Res.
21(Suppl. A):59-87[Medline].
|
| 59.
|
Salthouse, T. N.
1976.
Cellular enzyme activity at the polymer-tissue interface: a review.
J. Biomed. Mater. Res.
10:197-229[Medline].
|
| 60.
|
Schwarzmann, S., and J. R. Boring.
1971.
Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa.
Infect. Immun.
3:762-766[Abstract/Free Full Text].
|
| 61.
|
Selsted, M. E.,
D. Szklarek,
T. Ganz, and R. I. Lehrer.
1985.
Activity of rabbit leukocyte peptides against Candida albicans.
Infect. Immun.
49:202-206[Abstract/Free Full Text].
|
| 62.
|
Sengelov, H.,
P. Follin,
L. Kjeldsen,
K. Lollike,
C. Dahlgren, and N. Borregaard.
1995.
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
J. Immunol.
154:4157-4165[Abstract].
|
| 63.
|
Sengelov, H.,
L. Kjeldsen, and N. Borregaard.
1993.
Control of exocytosis in early neutrophil activation.
J. Immunol.
150:1535-1543[Abstract].
|
| 64.
|
Shanbhag, A.,
J. Yang,
J. Lilien, and J. Black.
1992.
Decreased neutrophil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in vitro.
J. Biomed. Mater. Res.
26:185-195[Medline].
|
| 65.
|
Sheu, M. J.,
W. W. Baldwin, and K. W. Brunson.
1985.
Cytotoxicity of rabbit macrophage peptides MCP-1 and MCP-2 for mouse tumor cells.
Antimicrob. Agents Chemother.
28:626-629[Abstract/Free Full Text].
|
| 66.
|
Sugarman, B., and E. J. Young.
1989.
Infections associated with prosthetic devices: magnitude of the problem.
Infect. Dis. Clin. N. Am.
3:187-198[Medline].
|
| 67.
|
Tal, T., and I. Aviram.
1993.
Defensin interferes with the activation of neutrophil NADPH oxides in a cell-free system.
Biochem. Biophys. Res. Commun.
196:636-641[Medline].
|
| 68.
|
Tal, T.,
M. Sharabani, and I. Aviram.
1998.
Cationic proteins of neutrophil azurophilic granules: protein-protein interaction and blockade of NADPH oxidase activation.
J. Leukoc. Biol.
63:305-311[Abstract].
|
| 69.
|
Wade, B. H., and G. L. Mandell.
1983.
Polymorphonuclear leukocytes: dedicated professional phagocytes.
Am. J. Med.
74:686-693[Medline].
|
| 70.
|
Wang, I.,
J. M. Anderson,
M. R. Jacobs, and R. E. Marchant.
1995.
Adhesion of Staphylococcus epidermidis to biomedical polymers: contributions of surface thermodynamics and hemodynamic shear conditions.
J. Biomed. Mater. Res.
29:485-493[Medline].
|
| 71.
|
Wang, I.,
J. M. Anderson, and R. E. Marchant.
1993.
Staphylococcus epidermidis adhesion to hydrophobic biomedical polymer is mediated by platelets.
J. Infect. Dis.
167:329-336[Medline].
|
| 72.
|
Wright, D. G.,
D. A. Bralove, and J. I. Gallin.
1977.
The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187.
Am. J. Pathol.
87:273-284.
|
| 73.
|
Wright, D. G., and J. I. Gallin.
1979.
Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo.
J. Immunol.
123:285-294[Abstract/Free Full Text].
|
| 74.
|
Yeaman, M. R.,
A. S. Bayer,
S.-P. Koo,
W. Foss, and P. M. Sullam.
1998.
Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.
J. Clin. Investig.
101:178-187[Medline].
|
| 75.
|
Yomogida, S.,
I. Nagaoka,
K. Saito, and T. Yamashita.
1996.
Evaluation of the effects of defensins on neutrophil functions.
Inflamm. Res.
45:62-67[Medline].
|
| 76.
|
Young, E. J., and B. Sugarman.
1988.
Infections in prosthetic devices.
Surg. Clin. N. Am.
68:167-180.
|
| 77.
|
Ziats, N.,
K. Miller, and J. M. Anderson.
1988.
In vitro and in vivo interactions of cells with biomaterials.
Biomaterials
9:5-13[Medline].
|
| 78.
|
Zimmerli, W.,
P. D. Lew, and F. A. Waldvogel.
1984.
Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.
J. Clin. Investig.
73:1191-1200.
|
| 79.
|
Zimmerli, W.,
F. A. Waldvogel,
P. Vandaux, and V. E. Nydegger.
1982.
Pathogenesis of foreign body infection: description and characteristics of an animal model.
J. Infect. Dis.
146:487-497[Medline].
|
Infection and Immunity, April 1999, p. 1640-1645, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tecle, T., White, M. R., Gantz, D., Crouch, E. C., Hartshorn, K. L.
(2007). Human Neutrophil Defensins Increase Neutrophil Uptake of Influenza A Virus and Bacteria and Modify Virus-Induced Respiratory Burst Responses. J. Immunol.
178: 8046-8052
[Abstract]
[Full Text]
-
Detilleux, J. C.
(2004). Neutrophils in the War Against Staphylococcus aureus: Predator-Prey Models to the Rescue. J DAIRY SCI
87: 3716-3724
[Abstract]
[Full Text]
-
Zimmerli, W., Trampuz, A., Ochsner, P. E.
(2004). Prosthetic-Joint Infections. NEJM
351: 1645-1654
[Full Text]
-
Porro, G. A., Lee, J.-H., de Azavedo, J., Crandall, I., Whitehead, T., Tullis, E., Ganz, T., Liu, M., Slutsky, A. S., Zhang, H.
(2001). Direct and indirect bacterial killing functions of neutrophil defensins in lung explants. Am. J. Physiol. Lung Cell. Mol. Physiol.
281: L1240-L1247
[Abstract]
[Full Text]
-
Zhang, H., Porro, G., Orzech, N., Mullen, B., Liu, M., Slutsky, A. S.
(2001). Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am. J. Physiol. Lung Cell. Mol. Physiol.
280: L947-L954
[Abstract]
[Full Text]
-
Boelens, J. J., van der Poll, T., Zaat, S. A. J., Murk, J. L. A. N., Weening, J. J., Dankert, J.
(2000). Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible to Staphylococcus epidermidis Biomaterial-Associated Infection than Are Wild-Type Mice. Infect. Immun.
68: 6924-6931
[Abstract]
[Full Text]